re: Ann: MD and CEO Dr Collier presents at BI... Partnering is the only way forward for CPn10. From information available from the old management, it would take $5M just to have a production run for new drug. I would expect a similar amount to do meaningful trials. I can't see the market being happy with such a raise, particularly just after the last one. I totally support the present management approach. CPn10 is a depreciating asset. Our patents have a finite end date and every day we are not doing trials is money lost. What this asset needs is a large injection of cash to allow trials on a number of indications simultaneously so that we get maximum return before patents expire. Hopefully any potential partner will well understand this. Present management seem to.
- Forums
- ASX - By Stock
- IVX
- Ann: MD and CEO Dr Collier presents at BIO Asia T
Ann: MD and CEO Dr Collier presents at BIO Asia T, page-3
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $23.11M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $5.119K | 1.422M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 19915859 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 2220375 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 19915859 | 0.003 |
8 | 10783666 | 0.002 |
10 | 15400000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 2220375 | 7 |
0.005 | 9278276 | 25 |
0.006 | 3148726 | 10 |
0.007 | 3518975 | 7 |
0.008 | 4405000 | 5 |
Last trade - 14.32pm 30/07/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online